Since TCF3-ZNF384 was the most recurrent amongZNF384-related fusion genes detected in the pediatricBCP-ALL patients, we next compared the characteristicsof TCF3-ZNF384-positive patients with those of wild-type ZNF384, as well as EP300-ZNF384- and TCF3-PBX1-positive patients (Table 2). When compared with wild-type ZNF384, initial WBC counts and a trend to be classi-fied in higher risk groups (IR and HR) were significantlyhigher in TCF3-ZNF384-positive patients (P